Notably, however, changes in Keap1-Nrf2 signalling have been observed in postmortem brain tissue from patients with major depressive disorder and bipolar disorder which showed marked reductions in protein levels of Keap1 and Nrf2 in the parietal cortex compared to the control group [133]. The gene discussed is KEAP1; the disease is major depressive disorder.